T1	Participants 123 168	squamous cell carcinomas of the head and neck
T2	Participants 358 411	squamous cell carcinomas of the head and neck (HNSCC)
T3	Participants 757 873	Eight hundred and three patients with representative pretreatment tissue samples from the randomized DAHANCA 6 and 7
